These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19038297)

  • 1. Better design of drug-eluting stents using computer modeling.
    Park K
    J Control Release; 2009 Jan; 133(1):1. PubMed ID: 19038297
    [No Abstract]   [Full Text] [Related]  

  • 2. Luminal flow patterns dictate arterial drug deposition in stent-based delivery.
    Kolachalama VB; Tzafriri AR; Arifin DY; Edelman ER
    J Control Release; 2009 Jan; 133(1):24-30. PubMed ID: 18926864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents.
    Mongrain R; Faik I; Leask RL; Rodés-Cabau J; Larose E; Bertrand OF
    J Biomech Eng; 2007 Oct; 129(5):733-42. PubMed ID: 17887899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-eluting stents - new standard of restenosis treatment].
    Koziński M; Kubica J
    Kardiol Pol; 2009 May; 67(5):539-49. PubMed ID: 19521942
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viewpoint: drug eluting stents.
    Gershlick AH
    Circulation; 2006 Feb; 113(6):f23-4. PubMed ID: 16479633
    [No Abstract]   [Full Text] [Related]  

  • 8. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success.
    Romero K; Corrigan B; Tornoe CW; Gobburu JV; Danhof M; Gillespie WR; Gastonguay MR; Meibohm B; Derendorf H
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):9S-19S. PubMed ID: 20881213
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
    Yu XQ; Wilson AG
    Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse-engineering clinical biology. A peacetime dividend yields drug trials on virtual patients.
    Stix G
    Sci Am; 2003 Feb; 288(2):18-9. PubMed ID: 12561454
    [No Abstract]   [Full Text] [Related]  

  • 15. Late in-stent restenosis in a patient with drug-eluting stent.
    Sultan FA; Kazmi K; Dhakam S; Quraishi AU
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer stents: looking at the horizon.
    Ramcharitar S; Serruys PW
    Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.